logo
Twitter
Discord
Email
logo
logo
ARS Pharmaceuticals, Inc.NASDAQ - SPRY
Reports
Search reports
Name
Reporting Date
Filing Date
2024-09-30 10-Q2024-09-302024-12-06
2024-09-30 10-Q2024-09-302024-11-13
2024-06-30 10-Q2024-06-302024-08-06
2024-03-31 10-Q2024-03-312024-05-09
2023-12-31 10-K2023-12-312024-03-21
2023-09-30 10-Q2023-09-302023-11-09
2023-06-30 10-Q2023-06-302023-08-10
2023-03-31 10-Q2023-03-312023-05-15
2022-12-31 10-K2022-12-312023-03-23
2022-09-30 10-Q2022-09-302022-11-02
2022-06-30 10-Q2022-06-302022-08-11
2022-03-31 10-Q2022-03-312022-05-12
2021-12-31 10-K2021-12-312022-03-31
2021-09-30 10-Q2021-09-302021-11-10
2021-06-30 10-Q2021-06-302021-08-12
2021-03-31 10-Q2021-03-312021-05-13
2020-12-31 10-K2020-12-312021-03-29
1
20 / page
About
Name
ARS Pharmaceuticals, Inc.
Overview
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Show More
CEO
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Industry
Biotechnology
Exchange
NASDAQ
Listing Date
2020-12-04
Address
11682 El Camino Real, Suite 120, San Diego, CA, 92130, United States
Tel
858-771-9307
Website
https://ars-pharma.com